The Clinical Outcome and the Exploration of Related Biomarkers of Target Therapy in Metastasis Colorectal Cancer

Huazhong University of Science and Technology

Status: Unknown

Conditions: Neoplasms, Therapy-Associated

Study type: Observational

Funder types: Other

Identifiers

NCT02523495

TJCC003-TTMCRC

Details and patient eligibility

About

Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer and explore some biomarkers that relate to target therapy.

Full description

1. Establish a clinical database of patients who are diagnosed with metastasis colorectal cancer in tongji hospital.
2. Build a biological specimen banks of metastasis colorectal cancer through collecting blood samples from those patients who have reached an agreement with us.
3. Through clinical observation and data statistics, conclude the clinical outcome of target therapy in metastasis colorectal cancer.
4. To extract DNA from the blood and explore some biomarkers that related to target therapy in metastasis colorectal cancer.

Enrollment: 120 estimated patients

Sex: All

Volunteers: No Healthy Volunteers

Inclusion criteria

1. Metastasis colorectal cancer confirmed by histologically and radiography
2. Receive target therapy over half a year
3. Have a measurable lesions

Exclusion criteria

1. A history of other malignant tumors in five years